chamaejasmine: isolated from Stellera chamaejasmae; structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Stellera | genus | [no description available] | Thymelaeaceae | A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mainly trees and shrubs. Many members contain mucilage and COUMARINS.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 155320 |
MeSH ID | M0499498 |
Synonym |
---|
(2r,3s)-3-[(2r,3s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one |
chamaejasmine |
(3,3'-bi-4h-1-benzopyran)-4,4'-dione, 2,2',3,3'-tetrahydro-5,5',7,7'-tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-, (2r,2'r,3s,3's)-rel- |
69618-96-8 |
(+-)-chamaejasmine |
dl-chamaejasmine |
DTXSID90219886 |
2,2',3,3'-tetrahydro-5,5',7,7'-tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-3,3'-bi[4h-1-benzopyran]-4,4'-dione |
HY-N10093 |
CS-0255540 |
AKOS040763453 |
Chamaejasmine is a promising anti-cancer agent in OS treatment. Further studies are needed to confirm its efficacy and safety.
Excerpt | Reference | Relevance |
---|---|---|
"Chamaejasmine is a promising anti-cancer agent in OS treatment, and further studies are needed to confirm its efficacy and safety" | ( The role of chamaejasmine in cellular apoptosis and autophagy in MG-63 cells. Li, Z; Ma, R; Wang, K; Wu, J; Yang, D; Yang, F; Zhang, H, 2019) | 1.61 |
Excerpt | Reference | Relevance |
---|---|---|
"Chamaejasmine treatment of MDA-MB-231 cells resulted in induction of WAF1/p21 and KIP1/p27, decrease in cyclins A and cyclins B1." | ( Chamaejasmine arrests cell cycle, induces apoptosis and inhibits nuclear NF-κB translocation in the human breast cancer cell line MDA-MB-231. Bai, Y; Cai, L; Dong, G; Yu, H; Zhang, T, 2013) | 2.55 |
Excerpt | Reference | Relevance |
---|---|---|
"91%, respectively), were separated by semi-preparative high-performance liquid chromatography combined with high-speed counter-current chromatography." | ( Development of a method to screen and isolate bioactive constituents from Stellera chamaejasme by ultrafiltration and liquid chromatography combined with semi-preparative high-performance liquid chromatography and high-speed counter current chromatography Hou, W; Huang, Y; Li, S; Liu, C; Wu, T; Xia, J, 2019) | 0.51 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 10 (83.33) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |